# High-Dose Melphalan, Total-Body Irradiation, and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma in First Relapse

> **NCT00002630** · PHASE2 · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 50 (estimated)

## Conditions studied

- Multiple Myeloma and Plasma Cell Neoplasm

## Interventions

- **BIOLOGICAL:** filgrastim
- **DRUG:** cyclophosphamide
- **DRUG:** melphalan
- **PROCEDURE:** peripheral blood stem cell transplantation
- **RADIATION:** low-LET cobalt-60 gamma ray therapy
- **RADIATION:** low-LET photon therapy

## Key facts

- **NCT ID:** NCT00002630
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1993-06
- **Primary completion:** 1999-02
- **Final completion:** 2001-05
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2011-05-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00002630

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00002630, "High-Dose Melphalan, Total-Body Irradiation, and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma in First Relapse". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT00002630. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*